08.04.20
Stratum Nutrition and KD Pharma are working in partnership to launch a unique joint health formula which combines Stratum’s branded eggshell membrane, NEM, and KD Pharma’s marine omega-3 oils, called MOVE3. The product, delivered in a softgel, was evaluated in a recently-published study evaluating the combination’s affect on joint pain and stiffness following exercise.
The International Journal of Physical Medicine and Rehabilitation recently published the randomized, double-blind, placebo-controlled study, which was designed to evaluate whether the combination of NEM brand eggshell membrane and KR Pür brand concentrated omega-3 EPA/DHA from fish oil would be able to reduce cartilage turnover and alleviate joint pain and/or stiffness immediately following exercise, and 12 hours post-exercise in 85 healthy men and women between the ages of 40 and 75 years old. The participants each performed a step exercise regimen on alternating days for two consecutive weeks, which involved stepping onto a platform 40-100 times on each leg. Participants were required to take a washout period for any drugs or supplements used for pain relief, though acetaminophen was permitted for emergency pain relief rescue.
The Move3 supplementation group had exhibited statistically significant reductions in levels of CTX-II, a biomarker of cartilage degradation, versus placebo after 1 and 2 weeks of exercise, with reductions of 12.9% and 17.7%, respectively. Additionally, the extents of each subjects’ pain or stiffness following exercise was self-reported through a scored questionnaire. Those in the treatment group experienced reductions in joint pain immediately after exercise by 28.6% after one week, and reductions averaging 46.7% 12 hours after exercise.
“The body of science supporting exercise and recovery benefits for both omega-3 and NEM continues to grow, but this study is unique because it demonstrates benefits in healthy people consuming the Move3 formulation after they have exercised,” Adam Ismail, chief strategy officer of the KD Pharma Group, said. “For sports nutrition products, it is important that consumers be able to feel the benefit, and the fact that we saw a significant improvement compared to placebo means the subjects not only felt the impact of Move3 but observed the effects in a rapid timeframe.”
“Conducting this clinical trial in exercising healthy adults will allow brands to make label claims relating to joint pain and stiffness and even cartilage protection,” Kevin Ruff, PhD, MBA, senior director of scientific and regulatory affairs for Stratum Nutrition, said. “This is an additional benefit that Move3 provides beyond any other combination product on the market.”
The International Journal of Physical Medicine and Rehabilitation recently published the randomized, double-blind, placebo-controlled study, which was designed to evaluate whether the combination of NEM brand eggshell membrane and KR Pür brand concentrated omega-3 EPA/DHA from fish oil would be able to reduce cartilage turnover and alleviate joint pain and/or stiffness immediately following exercise, and 12 hours post-exercise in 85 healthy men and women between the ages of 40 and 75 years old. The participants each performed a step exercise regimen on alternating days for two consecutive weeks, which involved stepping onto a platform 40-100 times on each leg. Participants were required to take a washout period for any drugs or supplements used for pain relief, though acetaminophen was permitted for emergency pain relief rescue.
The Move3 supplementation group had exhibited statistically significant reductions in levels of CTX-II, a biomarker of cartilage degradation, versus placebo after 1 and 2 weeks of exercise, with reductions of 12.9% and 17.7%, respectively. Additionally, the extents of each subjects’ pain or stiffness following exercise was self-reported through a scored questionnaire. Those in the treatment group experienced reductions in joint pain immediately after exercise by 28.6% after one week, and reductions averaging 46.7% 12 hours after exercise.
“The body of science supporting exercise and recovery benefits for both omega-3 and NEM continues to grow, but this study is unique because it demonstrates benefits in healthy people consuming the Move3 formulation after they have exercised,” Adam Ismail, chief strategy officer of the KD Pharma Group, said. “For sports nutrition products, it is important that consumers be able to feel the benefit, and the fact that we saw a significant improvement compared to placebo means the subjects not only felt the impact of Move3 but observed the effects in a rapid timeframe.”
“Conducting this clinical trial in exercising healthy adults will allow brands to make label claims relating to joint pain and stiffness and even cartilage protection,” Kevin Ruff, PhD, MBA, senior director of scientific and regulatory affairs for Stratum Nutrition, said. “This is an additional benefit that Move3 provides beyond any other combination product on the market.”
